Skip to content

Drug interactions

Momelotinib + Pantoprazole

Severity: Minor

Momelotinib and Pantoprazole: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Momelotinib inhibits BCRP and may increase the exposure of pantoprazole, which is a BCRP substrate. The effect is probably small given pantoprazole's safety margin.

What this interaction means in plain words

Momelotinib and Pantoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Momelotinib belongs to Oncology; Pantoprazole belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Momelotinib inhibits the BCRP efflux transporter, increasing pantoprazole exposure.

What to do

No routine dose change is required. Monitor for PPI adverse effects and reduce the dose if they occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Momelotinib and Pantoprazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Momelotinib with Pantoprazole?

MediHelp rates the interaction as minor. Momelotinib and Pantoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Momelotinib inhibits BCRP and may increase the exposure of pantoprazole, which is a BCRP substrate. The effect is probably small given pantoprazole's safety margin.

How serious is the interaction between Momelotinib and Pantoprazole?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is required. Monitor for PPI adverse effects and reduce the dose if they occur.

What other medicines interact with Pantoprazole?

MediHelp also lists interactions of Pantoprazole with, for example, Rilpivirine, Acalabrutinib, Atazanavir. The full list is on the Pantoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in